BCRX
BioCryst Pharmaceuticals Inc
8.60$
+0.8%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -1.1% | -9.5% | +1.0% | +4.0% | -0.2% | -2.1% | -4.8% | -2.4% | +15.2% | -9.6% | +20.0% | |
| – | -1.3% | -9.9% | -18.7% | +17.5% | -1.2% | -2.8% | -2.8% | -10.7% | +13.7% | -7.6% | +29.7% | |
| – | -26.7% | -23.8% | -7.0% | +24.5% | +7.4% | +0.5% | -16.5% | -4.5% | +6.7% | +92.2% | -10.1% | |
| – | -2.2% | -13.5% | -19.2% | +21.6% | -3.0% | -8.0% | -12.0% | -18.1% | +29.1% | -12.9% | +47.4% | |
| – | +6.2% | +6.4% | +13.5% | +5.4% | +9.1% | +18.1% | -2.4% | +0.2% | +17.0% | +2.3% | +1.4% | |
| – | -3.2% | +3.8% | -85.1% | +69.9% | +6.9% | -15.0% | -26.6% | +3.7% | +3.2% | +10.9% | +1.2% | |
| – | +4.1% | -2.9% | +0.4% | +1.2% | +0.7% | -3.6% | -5.7% | -5.1% | -24.1% | +60.9% | -0.7% | |
| – | +65.3% | -20.0% | +7.6% | +19.0% | +4.4% | -12.8% | +26.7% | +7.4% | +3.1% | -0.3% | +6.9% | |
| – | +16.0% | +3.5% | -1.2% | +1,225.7% | -1.2% | +4.9% | -94.6% | +1,865.6% | -95.9% | +2,564.8% | -93.1% | |
| – | +97.7% | -43.0% | -34.6% | +73.2% | -13.6% | -13.7% | -14.5% | -35.2% | +184.3% | -30.8% | +4.6% | |
| – | -2.6% | +0.2% | -0.6% | -1.5% | 0.0% | -1.7% | -11.7% | -8.3% | -32.6% | +87.8% | -3.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +6.2% | +2.3% | +0.2% | +0.2% | +0.2% | +3.8% | +2.1% | 0.0% | -0.3% | +10.5% | +9.5% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.